Urinary alcohol and ethyl glucuronide as a screening tool for alcohol use in pregnancy: A multicenter prospective study
Acta Obstetricia et Gynecologica Scandinavica · 2026
DOI: 10.1111/aogs.70164 ↗At a glance
Multizentrische Studie in Acta Obstetricia et Gynecologica Scandinavica, 2026. Written by Ciara A McCormick and 10 co-authors. Institution: National Maternity Hospital, Dublin, Ireland. Major MEDLINE topics: Glucuronates, Alcohol Drinking, Ethanol, Substance Abuse Detection. 20 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Drug Treatment Centre.
Abstract (original language)
Introduction
Reports indicate that up to 60% of pregnant women in Ireland consume alcohol and Ireland may have the third highest prevalence of fetal alcohol syndrome in the world. We sought objective evidence of alcohol intake and the acceptability of urinary alcohol screening. Material and Methods This was a multicenter, prospective study conducted at one urban and two semirural maternity units. Pregnant women at their first visit (≈13 weeks gestation) were invited to participate. Urinary samples were obtained with individual consent. Samples were anonymized and tested for alcohol and ethyl glucuronide at a central laboratory. The rate of sample positivity for ethanol (at a cut‐off of 30 mg/dL) and ethyl glucuronide (at a cut‐off of 500 ng/mL) was reported. The percentage of women consenting to testing was recorded. Results were compared with previous questionnaire or interview‐based studies.
Results
One thousand fifty‐three urine samples were analyzed. None tested positive for ethanol but 4/1053 (0.38%) contained ethyl glucuronide. Three samples were positive in the urban cohort, 3/730 (0.41%) and 1/323 (0.31%) in the semirural centers. Consent was obtained in 96% and 98% in two semirural centers compared to 78% in the urban center (565/722 vs. 323/336. p < 0.01). Acceptability in the urban center depended on who requested consent and varied between 65% and 100% ( p < 0.01). Consent to participate was significantly higher and detected alcohol use was significantly lower than in previous, interview or questionnaire‐based studies.
Conclusions
Alcohol intake appears to be much less common than previously estimated. The consent rates for urinary alcohol testing are high and are influenced by who is requesting consent.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- National Maternity Hospital, Dublin, Ireland.
- UCD Perinatal Research Centre, National Maternity Hospital, University College Dublin, Dublin, Ireland.
- National Drug Treatment Centre, Dublin, Ireland.
- Wexford General Hospital, Wexford, Ireland.
- St Lukes's Hospital, Kilkenny, Ireland.
- Liver Unit, St Vincent's University Hospital, Dublin, Ireland.
ORCID profiles: Ciara A McCormick, Fionnuala M McAuliffe
Funding
- National Drug Treatment Centre
Cite
APA
McCormick, C. A., Mealy, G., Donaghy, C., Gordon, P., Dunn, E., Carroll, P., Rodriguez-Herrera, A., Cusnaider, C. M., Ebbitt, W., McCormick, P. A., & McAuliffe, F. M. (2026). Urinary alcohol and ethyl glucuronide as a screening tool for alcohol use in pregnancy: A multicenter prospective study. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.70164
Vancouver
McCormick CA, Mealy G, Donaghy C, Gordon P, Dunn E, Carroll P, et al. Urinary alcohol and ethyl glucuronide as a screening tool for alcohol use in pregnancy: A multicenter prospective study. Acta Obstetricia et Gynecologica Scandinavica. 2026. doi:10.1111/aogs.70164
BibTeX
@article{McCormick2026,
author = {McCormick, Ciara A and Mealy, Grace and Donaghy, Caroline and Gordon, Patricia and Dunn, Elizabeth and Carroll, Pauline and Rodriguez-Herrera, Alfonso and Cusnaider, Conrado M and Ebbitt, William and McCormick, Peter A and McAuliffe, Fionnuala M},
title = {Urinary alcohol and ethyl glucuronide as a screening tool for alcohol use in pregnancy: A multicenter prospective study},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
year = {2026},
doi = {10.1111/aogs.70164}
}
EUVIMED